| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eca3764daf7c19cf873fb5f494b27c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9beae656a28ded212cf39a4d26f76bfb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a39b773ab60e1602c797adbb7a9a0bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d30b384508e2547d98ef2a97f3a9ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31d13a6b1dc47bf23b7ef8d6570bb46a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f3e89b9d6b30e6811992a9ea7bcdf49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db565850ac774f5cf04ca505d37f9421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_202882a78399ca705d36130a26765c45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d70062796db6c28ca7fbed59482d9c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9fe897c3602fc1caa9be3556482b53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acd2a1540eddb15b482067fe54783cba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d512b51149083c9053f392251e8da9c |
| publicationDate |
2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2431914-A1 |
| titleOfInvention |
ANTI-HER2 human monoclonal antibody |
| abstract |
Anti-HER2 human monoclonal antibody. # The present invention relates to a human monoclonal antibody that recognizes the extracellular domain of human epidermal growth factor receptor 2 (HER2) and is produced in human embryonic retinal cells. Likewise, the present invention relates to the use of said antibody to measure the level of HER2 expression and for the preparation of a medicament for the treatment of neoplastic disorders that occur with HER2 overexpression. |
| priorityDate |
2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |